TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05).

Chen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.